EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LDT’s in Flux: Will Evolving Regulations Enhance or Complicate Laboratory Practices?

Alejandro R Molinelli iD, Dennis J Dietzen iD, Jonathan R Genzen, Xander M R van Wijk, Maria Alice V Willrich, Melissa M Budelier iD

Journal of Mass Spectrometry and Advances in the Clinical Lab · 29.07.2026 · 39 (1)

DOI: 10.21627/ggcs2a65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry and Advances in the Clinical Lab, online erschienen am 29.07.2026. Verfasst von Alejandro R Molinelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical labs help diagnose and manage disease by testing blood and other specimens. They operate under federal rules known as Clinical Laboratory Improvement Amendments (CLIA). Most tests are FDA cleared/approved, but some are laboratory-developed tests (LDTs) created in individual labs, typically to meet unmet needs. LDTs have long existed in a complicated regulatory space. In 2024, the FDA issued a rule to regulate LDTs like devices, prompting concerns about cost, innovation, and access. A federal court struck the rule down in 2025, finding LDTs are services, not devices. The FDA subsequently rescinded its rule. In this article, experts argue that LDTs are essential and already held to strong standards and that future reforms should strengthen CLIA while protecting access and innovation.

Schlagwörter

Stichwörter der Autor:innen

CLIAFDALaboratory developed testqualityregulatory

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, AZ, United States.
  • Department of Pathology, University of Utah, Salt Lake City, UT, United States.
  • ARUP Laboratories, Salt Lake City, UT, United States.
  • Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.

ORCID-Profile: Alejandro R Molinelli, Dennis J Dietzen, Melissa M Budelier

Zitieren

APA

Molinelli, A. R., Dietzen, D. J., Genzen, J. R., van Wijk, X. M. R., Willrich, M. A. V., & Budelier, M. M. (2026). LDT’s in Flux: Will Evolving Regulations Enhance or Complicate Laboratory Practices?. Journal of Mass Spectrometry and Advances in the Clinical Lab, 39(1). https://doi.org/10.21627/ggcs2a65

Vancouver

Molinelli AR, Dietzen DJ, Genzen JR, van Wijk XMR, Willrich MAV, Budelier MM. LDT’s in Flux: Will Evolving Regulations Enhance or Complicate Laboratory Practices?. Journal of Mass Spectrometry and Advances in the Clinical Lab. 2026;39(1). doi:10.21627/ggcs2a65

BibTeX
@article{Molinelli2026,
  author = {Molinelli, Alejandro R and Dietzen, Dennis J and Genzen, Jonathan R and van Wijk, Xander M R and Willrich, Maria Alice V and Budelier, Melissa M},
  title = {LDT’s in Flux: Will Evolving Regulations Enhance or Complicate Laboratory Practices?},
  journal = {Journal of Mass Spectrometry and Advances in the Clinical Lab},
  year = {2026},
  volume = {39},
  number = {1},
  doi = {10.21627/ggcs2a65}
}
Kostenlos starten →